专利检索 ap:("Tomoya MIURA" OR "Yosuke OGOSHI" OR "Kazuhito UEYAMA" OR "Dai MOTODA" OR "Toshihiko IWAYAMA" OR "Koichi SUZAWA" OR "Hironobu NAGAMORI" OR "Hiroshi UENO" OR "Akihiko TAKAHASHI" OR "Kazuyuki SUGIMOTO") AND inv:"Tomoya MIURA" 第 1 页

1.

发明申请
PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF 有权

公开(公告)号：US20130085132A1

公开(公告)日：2013-04-04

申请号：US13599665

申请日：2012-08-30

申请人： Tomoya MIURA , Yosuke OGOSHI , Kazuhito UEYAMA , Dai MOTODA , Toshihiko IWAYAMA , Koichi SUZAWA , Hironobu NAGAMORI , Hiroshi UENO , Akihiko TAKAHASHI , Kazuyuki SUGIMOTO

发明人： Tomoya MIURA , Yosuke OGOSHI , Kazuhito UEYAMA , Dai MOTODA , Toshihiko IWAYAMA , Koichi SUZAWA , Hironobu NAGAMORI , Hiroshi UENO , Akihiko TAKAHASHI , Kazuyuki SUGIMOTO

IPC分类号： C07D403/12 , C07D405/12 , C07D403/14 , C07D413/12 , C07D409/12 , C07D401/12 , C07D405/14

CPC分类号： C07D403/12 , C07D401/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12

摘要： The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use: wherein each symbol is the same as defined in the description.